Journal article

Bipolar mixed states: still mixed up?

David J Castle

Current Opinion in Psychiatry | LIPPINCOTT WILLIAMS & WILKINS | Published : 2014

University of Melbourne Researchers


Funding Acknowledgements

David Castle has received grant monies for research from Eli Lilly, Janssen Cilag, Roche, Allergen, Bristol-Myers Squibb, Pfizer, Lundbeck, Astra Zeneca, Hospira; Travel Support and Honoraria for Talks and Consultancy from Eli Lilly, Bristol-Myers Squibb, Astra Zeneca, Lundbeck, Janssen Cilag, Pfizer, Organon, Sanofi-Aventis, Wyeth, Hospira, Servier; and is currently an Advisory Board Member for Lu AA21004: Lundbeck; Pristiq: Pfizer; Varenicline: Pfizer; Asenapine: Lundbeck; Seroquel: Astra Zeneca. He has no stocks or shares in any pharmaceutical company.